Pharmacokinetic interaction between amitriptyline and neuroleptics. 1978

A Jus, and J Gautier, and A Villeneuve, and K Jus, and P Pires, and M Gagnon-Binette, and C Fortin

The influence of amitriptyline on the plasma level of various neuroleptics was studied in 25 chronic schizophrenic patients. The study lasted 20 weeks. Patients were kept first 4 weeks on their former neuroleptic medication, with amitriptyline added for 12 subsequent weeks, and withdrawn during the last 4 weeks when only the neuroleptic medication was continued unchanged. The plasma level of neuroleptics was assayed by gas-liquid chromatography, once weekly throughout the study. The amitriptyline plasma level was also evaluated once weekly during the 12 weeks of its administration. The mean neuroleptic plasma values for each 4-week period were pooled together in three groups: aliphatic, piperdine and piperazine phenothiazine derivatives. Amitriptyline provoked some increase of the plasma level of all phenothiazine derivatives. This augmentation was significant only transitorily, however. The putative mechanisms of this neuroleptic tricyclic antidepressant interaction are discussed.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000639 Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines. Amineurin,Amitrip,Amitriptylin Beta,Amitriptylin Desitin,Amitriptylin RPh,Amitriptylin-Neuraxpharm,Amitriptyline Hydrochloride,Amitrol,Anapsique,Apo-Amitriptyline,Damilen,Domical,Elavil,Endep,Laroxyl,Lentizol,Novoprotect,Saroten,Sarotex,Syneudon,Triptafen,Tryptanol,Tryptine,Tryptizol,Amitriptylin Neuraxpharm,Apo Amitriptyline,Desitin, Amitriptylin,RPh, Amitriptylin
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

A Jus, and J Gautier, and A Villeneuve, and K Jus, and P Pires, and M Gagnon-Binette, and C Fortin
October 2005, Therapeutic drug monitoring,
A Jus, and J Gautier, and A Villeneuve, and K Jus, and P Pires, and M Gagnon-Binette, and C Fortin
January 1991, Polish journal of pharmacology and pharmacy,
A Jus, and J Gautier, and A Villeneuve, and K Jus, and P Pires, and M Gagnon-Binette, and C Fortin
September 1974, Acta pharmacologica et toxicologica,
A Jus, and J Gautier, and A Villeneuve, and K Jus, and P Pires, and M Gagnon-Binette, and C Fortin
January 1983, European journal of clinical pharmacology,
A Jus, and J Gautier, and A Villeneuve, and K Jus, and P Pires, and M Gagnon-Binette, and C Fortin
May 1992, Naunyn-Schmiedeberg's archives of pharmacology,
A Jus, and J Gautier, and A Villeneuve, and K Jus, and P Pires, and M Gagnon-Binette, and C Fortin
January 1972, Nordisk psykiatrisk tidsskrift. Nordic journal of psychiatry,
A Jus, and J Gautier, and A Villeneuve, and K Jus, and P Pires, and M Gagnon-Binette, and C Fortin
May 1993, The American journal of psychiatry,
A Jus, and J Gautier, and A Villeneuve, and K Jus, and P Pires, and M Gagnon-Binette, and C Fortin
January 1985, Clinical pharmacokinetics,
A Jus, and J Gautier, and A Villeneuve, and K Jus, and P Pires, and M Gagnon-Binette, and C Fortin
June 1995, Pharmacological research,
A Jus, and J Gautier, and A Villeneuve, and K Jus, and P Pires, and M Gagnon-Binette, and C Fortin
January 1986, Psychopharmacology,
Copied contents to your clipboard!